Aurora Financial Advisors’s AstraZeneca AZN Stock Holding History

Aurora Financial Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$420K	Buy	+6,057	New	+$408K	0.3%	114

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Aurora Financial Advisors's AZN Position: Q4 2017 in Review

Aurora Financial Advisors opened a new position in AstraZeneca (AZN) in Q4 2017: 6,057 shares worth $420K. The stake represents 0.3% of the portfolio and ranks #114 among its holdings.

503 funds tracked by Wall St. Rank hold AZN as of Q4 2017.

Aurora Financial Advisors held 6,057 shares of AstraZeneca worth $420K as of Q4 2017.
AstraZeneca was a new Aurora Financial Advisors position in Q4 2017.
AstraZeneca made up 0.3% of Aurora Financial Advisors's portfolio in Q4 2017, its #114 holding.
503 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2017.

Based on Aurora Financial Advisors's 13F filing for Q4 2017, filed 16 Mar 2018.